Mostrar el registro sencillo del ítem

dc.contributor.author
Leotta, Gerardo Anibal  
dc.contributor.author
Miliwebsky, Elizabeth S.  
dc.contributor.author
Chinen, Isabel  
dc.contributor.author
Espinosa, Estela M.  
dc.contributor.author
Azzopardi, Kristy  
dc.contributor.author
Tennant, Sharon M.  
dc.contributor.author
Robins Browne, Roy M.  
dc.contributor.author
Rivas, Marta  
dc.date.available
2019-08-06T19:42:52Z  
dc.date.issued
2008-03  
dc.identifier.citation
Leotta, Gerardo Anibal; Miliwebsky, Elizabeth S.; Chinen, Isabel; Espinosa, Estela M.; Azzopardi, Kristy; et al.; Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand; BioMed Central; BMC Microbiology; 8; 3-2008; 1-8  
dc.identifier.issn
1471-2180  
dc.identifier.uri
http://hdl.handle.net/11336/81016  
dc.description.abstract
Background: Shiga toxin-producing Escherichia coli (STEC) is an important cause of bloody diarrhoea (BD), non-bloody diarrhoea (NBD) and the haemolytic uraemic syndrome (HUS). In Argentina and New Zealand, the most prevalent STEC serotype is O157:H7, which is responsible for the majority of HUS cases. In Australia, on the other hand, STEC O157:H7 is associated with a minority of HUS cases. The main aims of this study were to compare the phenotypic and genotypic characteristics of STEC O157 strains isolated between 1993 and 1996 from humans in Argentina, Australia and New Zealand, and to establish their clonal relatedness. Results: Seventy-three O157 STEC strains, isolated from HUS (n = 36), BD (n = 20), NBD (n = 10), or unspecified conditions (n = 7) in Argentina, Australia and New Zealand, were analysed. The strains were confirmed to be E. coli O157 by biochemical tests and serotyping. A multiplex polymerase chain reaction (PCR) was used to amplify the stx1, stx2 and rfbO157 genes and a genotyping method based on PCR-RFLP was used to determine stx1 and stx2 variants. This analysis revealed that the most frequent stx genotypes were stx2/stx 2c (vh-a) (91%) in Argentina, stx2 (89%) in New Zealand, and stx1/stx2 (30%) in Australia. No stx 1-postive strains were identified in Argentina or New Zealand. All strains harboured the eae gene and 72 strains produced enterohaemolysin (EHEC-Hly). The clonal relatedness of strains was investigated by phage typing and pulsed-field gel electrophoresis (PFGE). The most frequent phage types (PT) identified in Argentinian, Australian, and New Zealand strains were PT49 (n = 12), PT14 (n = 9), and PT2 (n = 15), respectively. Forty-six different patterns were obtained by XbaI-PFGE; 37 strains were grouped in 10 clusters and 36 strains showed unique patterns. Most clusters could be further subdivided by BlnI-PFGE. Conclusion: STEC O157 strains isolated in Argentina, Australia, and New Zealand differed from each other in terms of stx-genotype and phage type. Additionally, no common PFGE patterns were found in strains isolated in the three countries. International collaborative studies of the type reported here are needed to detect and monitor potentially hypervirulent STEC clones.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
BioMed Central  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/  
dc.subject
Escherichia Coli  
dc.subject
Shiga Toxin  
dc.subject
Humans  
dc.subject
Bloody Diarrhoea  
dc.subject
Haemolytic Uraemic Syndrome  
dc.subject
Haemolytic  
dc.subject
Syndrome  
dc.subject
Clonal Relatedness  
dc.subject
Toxin Profile  
dc.subject
Argentinian Strain  
dc.title
Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2019-07-12T16:15:43Z  
dc.journal.volume
8  
dc.journal.pagination
1-8  
dc.journal.pais
Reino Unido  
dc.journal.ciudad
Londres  
dc.description.fil
Fil: Leotta, Gerardo Anibal. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina  
dc.description.fil
Fil: Miliwebsky, Elizabeth S.. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina  
dc.description.fil
Fil: Chinen, Isabel. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina  
dc.description.fil
Fil: Espinosa, Estela M.. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina  
dc.description.fil
Fil: Azzopardi, Kristy. University of Melbourne; Australia  
dc.description.fil
Fil: Tennant, Sharon M.. University of Melbourne; Australia  
dc.description.fil
Fil: Robins Browne, Roy M.. University of Melbourne; Australia  
dc.description.fil
Fil: Rivas, Marta. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina  
dc.journal.title
BMC Microbiology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://bmcmicrobiol.biomedcentral.com/articles/10.1186/1471-2180-8-46  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1186/1471-2180-8-46